WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+17.78%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$9.17B
AUM Growth
+$9.17B
(+7.6%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
726
New
146
Increased
136
Reduced
152
Closed
261
Top Buys
| 1 |
TE Connectivity
TEL
|
$118M |
| 2 |
Ovintiv
OVV
|
$108M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$106M |
| 4 |
Amazon
AMZN
|
$86M |
| 5 |
Qorvo
QRVO
|
$80.1M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$238M |
| 2 |
Electronic Arts
EA
|
$107M |
| 3 |
Autodesk
ADSK
|
$95.8M |
| 4 |
Keysight
KEYS
|
$88.3M |
| 5 |
STMicroelectronics
STM
|
$82.2M |
Sector Composition
| 1 | Healthcare | 41.58% |
| 2 | Technology | 23.85% |
| 3 | Industrials | 10.4% |
| 4 | Energy | 8.49% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $198M | 2.15% | 1,274,697 +31,351 | +3% | +$4.86M |
|
2
Eli Lilly
LLY
$657B
| $185M | 2.01% | 317,071 +45,071 | +17% | +$26.3M |
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $149M | 1.62% | 170,090 +33,518 | +25% | +$29.4M |
|
4
Permian Resources
PR
$10B
| $138M | 1.5% | 10,135,065 +1,564,508 | +18% | +$21.3M |
|
|
5
Ovintiv
OVV
$10.8B
| $137M | 1.49% | 3,115,462 +2,464,289 | +378% | +$108M |
|
|
6
TE Connectivity
TEL
$61B
| $127M | 1.38% | 901,151 +842,827 | +1,445% | +$118M |
|
7
Analog Devices
ADI
$124B
| $125M | 1.36% | 628,903 -388,069 | -38% | -$77.1M |
|
8
Gilead Sciences
GILD
$140B
| $119M | 1.29% | 1,464,141 +763,205 | +109% | +$61.8M |
|
|
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $113M | 1.23% | 357,473 +334,751 | +1,473% | +$106M |
|
|
10
Qorvo
QRVO
$8.4B
| $108M | 1.18% | 962,947 +711,125 | +282% | +$80.1M |
|
11
Expedia Group
EXPE
$26.6B
| $89.7M | 0.98% | 591,099 +226,345 | +62% | +$34.4M |
|
12
Avantor
AVTR
$9.18B
| $89.1M | 0.97% | 3,903,582 +1,012,926 | +35% | +$23.1M |
|
|
INBX
13
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $88.1M | 0.96% | 2,318,576 +793,661 | +52% | +$30.2M |
|
14
Merck
MRK
$210B
| $86.6M | 0.94% | 794,456 -88,044 | -10% | -$9.6M |
|
15
L3Harris
LHX
$51.9B
| $86.5M | 0.94% | 410,854 -122,388 | -23% | -$25.8M |
|
|
16
Amazon
AMZN
$2.44T
| $86M | 0.94% | +566,298 | New | +$86M |
|
17
Meta Platforms (Facebook)
META
$1.86T
| $85.7M | 0.93% | 242,123 -122,776 | -34% | -$43.5M |
|
18
Revolution Medicines
RVMD
$7.1B
| $84.9M | 0.92% | 2,960,040 -185,405 | -6% | -$5.32M |
|
19
Avnet
AVT
$4.55B
| $84.8M | 0.92% | 1,682,357 +1,380,396 | +457% | +$69.6M |
|
20
Snowflake
SNOW
$79.6B
| $83.9M | 0.91% | 421,545 | – | – |
|
21
Johnson & Johnson
JNJ
$427B
| $80.9M | 0.88% | 515,900 -348,507 | -40% | -$54.6M |
|
22
ASML
ASML
$292B
| $78.3M | 0.85% | 103,451 -84,637 | -45% | -$64.1M |
|
23
Johnson Controls International
JCI
$69.9B
| $76.8M | 0.83% | 1,331,647 -178,343 | -12% | -$10.3M |
|
24
HubSpot
HUBS
$25.5B
| $76.4M | 0.83% | +131,531 | New | +$76.4M |
|
|
BPMC
25
DELISTED
Blueprint Medicines
BPMC
| $75.1M | 0.82% | 814,473 +212,446 | +35% | +$19.6M |
|